Genesis is proud to be part of the TIMBER Study, a collaborative initiative led by the University of Cape Town and implemented across South Africa, Kenya and The Gambia with the assistance of the respective country National Immunisation Technical Advisory Group (NITAG) leaders, working to make sure Africa is not left behind.

As a key partner in this comprehensive evaluation, Genesis Analytics led rigorous country-level case studies in Cameroon, Côte d'Ivoire, and Zambia, and a special study in the conflict-affected and fragile context of Somalia.

Genesis Analytics was contracted by IPM South Africa NPC, an affiliate of the Population Council to scale up the PrEP ring. 

Building on five years of success, in the third phase of the SSLN, we are supporting 16 African countries to strengthen their HIV prevention programmes through shared learning and action.

We collaborated with the National Institute for Communicable Diseases (NICD) on a significant longitudinal household cohort study in South Africa. This work was central to strengthening the country's system for monitoring vaccine-preventable illnesses and informing national immunisation policy.

We undertook a mixed-methods approach to understand the scale and nature of this issue. We conducted a comprehensive literature review and undertook key informant interviews to explore the reasons why people disengaged from HIV and TB treatment. This work uncovered important information about policy gaps, administrative hurdles, and stigma-related barriers. 

Global evidence suggests that integrating HIV services is essential for sustaining the HIV response, ending AIDS by 2030, and advancing universal health coverage.

Genesis Analytics has partnered with the Gates Foundation to explore the value of introducing and/or scaling up Wastewater and Environmental Surveillance (WES) as part of broader disease surveillance strategies.

Our approach involved a detailed examination of the complex, socio-behavioural factors that shaped the decision-making framework around seeking immunisation. Working with our consortium partner, Final Mile, we employed a human-centred design lens to thoroughly understand and iteratively test solutions to these gender-specific barriers. 

The core challenge was to determine if the GC7 FR-GM processes resulted in high-quality grants that genuinely aligned with national health priorities and supported the overarching GF strategy for 2023-2028. We needed to understand if the current procedures were fit for purpose and where they could be simplified or rationalised.

The Gates Foundation has awarded Genesis a grant to provide technical support to the National Department of Health as part of the foundation’s $2.5-million, three-year tuberculosis (TB) delivery strategy for South Africa.

Genesis undertook the evaluation of the Phase 1 implementation of the government’s policy of National Health Insurance (NHI) in South Africa. The main aim was to assess whether the NHI Phase 1 interventions had achieved their objective of health system strengthening in primary health care facilities.